Large-scale testing (Phase 3)Ended earlyNCT00562016What this trial is testingProtect II, A Prospective, Multicenter Randomized Controlled TrialWho this might be right forCoronary Artery Disease Abiomed Inc. 452
Testing effectiveness (Phase 2)Looking for participantsNCT07327840What this trial is testingPhase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)Who this might be right forLipoprotein Disorder Kylonova (Xiamen) Biopharma co., LTD. 204
Large-scale testing (Phase 3)Looking for participantsNCT06875973What this trial is testingPelacarsen Roll-over Extension ProgramWho this might be right forAtherosclerotic Cardiovascular Disease Novartis Pharmaceuticals 600
Testing effectiveness (Phase 2)Study completedNCT00534859What this trial is testingPROTECT I, A Prospective Feasibility Trial Investigating the Use of IMPELLA RECOVER LP 2.5 System in Patients Undergoing High Risk PCIWho this might be right forPatients Undergoing High Risk PCI. Abiomed Inc. 28
Testing effectiveness (Phase 2)Study completedNCT02241772What this trial is testingA Study on the Effects of TA-8995 on Lp(a) in Subjects With Elevated Lp(a)Who this might be right forElevated Lp(a) Xention Ltd 42
Not applicableLooking for participantsNCT06304415What this trial is testingElevated Lipoprotein(a) in Hospital StaffWho this might be right forHypercholesterolemiaLipoprotein Types--Lp System Lp(A) HyperlipoproteinemiaCardiovascular Diseases Changi General Hospital 2,800
Not applicableLooking for participantsNCT06439654What this trial is testingAtlantic Lipid Lowering Treatment Optimization ProgramWho this might be right forFamilial HypercholesterolemiaLipoprotein Types--Lp System Lp(A) HyperlipoproteinemiaApolipoprotein B 100, Familial Defective+2 more Atlantic Health System 250
Not applicableLooking for participantsNCT06482476What this trial is testingMedical Students' Evaluation of Dyslipidemia and LIPoprotein(a) StudyWho this might be right forInsight Into the Prevalence of Elevated Lp(a) Among Greek Medical Students University of Ioannina 246
Testing effectiveness (Phase 2)Study completedNCT05565742What this trial is testingLY3819469 in Participants With Elevated Lipoprotein(a) [Lp(a)]Who this might be right forLipoprotein Disorder Eli Lilly and Company 320
Not applicableUnknownNCT05323227What this trial is testingLp(a) With CCTA Assessed Parameters and Clinical OutcomesWho this might be right forCoronary Artery Disease Shanghai Zhongshan Hospital 378
Large-scale testing (Phase 3)Active Not RecruitingNCT06267560What this trial is testingLp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVDWho this might be right forElevated Lp(a) and Established Atherosclerotic Cardiovascular Disease Novartis Pharmaceuticals 422
Testing effectiveness (Phase 2)Study completedNCT04270760What this trial is testingOlpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction - DOSE Finding StudyWho this might be right forCardiovascular Disease Amgen 281
Early research (Phase 1)Looking for participantsNCT04573140What this trial is testingRNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)Who this might be right forAdult GlioblastomaHigh Grade GliomaWHO Grade III or IV Malignant Glioma University of Florida 28
Large-scale testing (Phase 3)Looking for participantsNCT07157774What this trial is testingAssessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)Who this might be right forElevated Lp(a)Atherosclerotic Cardiovascular Disease (ASCVD) Eli Lilly and Company 10,450
Large-scale testing (Phase 3)Study completedNCT02729025What this trial is testingEffects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoprotein(a) (Lp(a))Who this might be right forSubjects With Hyperlipidemia, Dyslipidemia Amgen 129
Not applicableWithdrawnNCT01064934What this trial is testingRandomized Controlled Trial of Lipid Apheresis in Patients With Elevated Lipoprotein(a)Who this might be right forHyperlipoproteinemia(a)Progressive Cardiovascular Disease Charite University, Berlin, Germany
Not applicableNot Yet RecruitingNCT07198009What this trial is testing2-HOBA Supplementation in People With Elevated Lipoprotein(a)Who this might be right forHyperlipidemiaElevated Lp(a) The Miriam Hospital 10
Not applicableWithdrawnNCT04993664What this trial is testingInfluence of Pelacarsen on Patients After Myocardial Infarction With High Lp(a) Values (PEMILA)Who this might be right forAcute Coronary SyndromeLipoproteinemiaInflammation+1 more University Medical Centre Ljubljana
Not applicableWithdrawnNCT02380534What this trial is testingUse of Apheretic Technologies in Cardiovascular DiseaseWho this might be right forDyslipidemia University of Pavia
Large-scale testing (Phase 3)Looking for participantsNCT06813911What this trial is testingLp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVDWho this might be right forAtherosclerotic Cardiovascular Disease (ASCVD) Novartis Pharmaceuticals 340